First person – Anaïs Kervadec and James Kezos

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Anaïs Kervadec and James Kezos are co-first authors on ‘ Multiplatform modeling of atrial fibrillation identifies phospholamban as a central regulator of cardiac rhythm’, published in DMM. Anaïs conducted the research described in this article while a postdoctoral associate in Alexandre Colas' lab at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA, and is now a scientist at Avidity Biosciences, La Jolla, CA, USA, utilising cutting-edge scientific approaches to discover molecular mechanisms of action, with the ultimate goal of developing novel therapies for patients in need. James is a postdoctoral fellow in the lab of Karen Ocorr at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA, utilising multimodel system approaches to investigate genetic, molecular and physiological mechanisms underlying cardiac development and disease.